CBPO [China Biologic Products] SC 13D/A: (Original Filing)

[Siu Ling Chan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 7 SOLE VOTING POWER 1 3,012,624 SHARES BENEFICIALLY]

CBPO [China Biologic Products] SC 13D/A: Siu Ling Chan 2 CHECK THE APPROPRIATE BOX

[Siu Ling Chan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 7 SOLE VOTING POWER 1 3,012,624 SHARES BENEFICIALLY]

CBPO [China Biologic Products] 8-K: (Original Filing)

[CREDIT AGREEMENT Dated as of February 25, 2014 between CHINA BIOLOGIC PRODUCTS, INC. as Borrower, and CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH as Lender TABLE OF CONTENTS Page No. SECTION 1 Definitions 1 1.1 Definitions 1 1.2 Other Definitional Provisions 8 1.3 Computation of Time Periods 8 1.4 Accounting Terms 8 SECTION 2 THE CREDIT FACILITIES 9 2.1] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26 , 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400023 DATE OF EXPIRY: February 25, 2016 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26, 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400024 DATE OF EXPIRY: August 25 , 2015 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400023 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400024 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [FOR RELEASE March 3, 2014 China Biologic Completes Stock Repurchase Transaction BEIJING, China – March 3, 2014 – Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “In the past six months, we have closed two share repurchase transactions totaling 3.98 million shares of common stock for a total consideration of $99.6 million. Through these repurchase] []

CBPO [China Biologic Products] 8-K: CREDIT AGREEMENT Dated as of February 25, 2014

[CREDIT AGREEMENT Dated as of February 25, 2014 between CHINA BIOLOGIC PRODUCTS, INC. as Borrower, and CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH as Lender TABLE OF CONTENTS Page No. SECTION 1 Definitions 1 1.1 Definitions 1 1.2 Other Definitional Provisions 8 1.3 Computation of Time Periods 8 1.4 Accounting Terms 8 SECTION 2 THE CREDIT FACILITIES 9 2.1] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26 , 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400023 DATE OF EXPIRY: February 25, 2016 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26, 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400024 DATE OF EXPIRY: August 25 , 2015 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400023 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400024 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [FOR RELEASE March 3, 2014 China Biologic Completes Stock Repurchase Transaction BEIJING, China – March 3, 2014 – Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “In the past six months, we have closed two share repurchase transactions totaling 3.98 million shares of common stock for a total consideration of $99.6 million. Through these repurchase] []

DATE [JIAYUAN.COM INTERNATIONAL] 6-K: (Original Filing)

[Jiayuan Announces Fourth Quarter and Full Year 2013 Financial Results BEIJING, China, February 27, 2014 — Jiayuan.com International Ltd. (“Jiayuan”) (NASDAQ: DATE), operator of the largest online dating platform in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter 2013 Highlights 1 · Net revenues for the fourth quarter] [333-173619 JIAYUAN.COM INTERNATIONAL LTD. F/15, Anhua Development Building No. 35 Anding Road Chaoyang District, Beijing The People’s Republic of China (8610) 6113-6312 Form 20-F o Form 40-F o o o Yes o No x 2]

DATE [JIAYUAN.COM INTERNATIONAL] 6-K: Jiayuan Announces Fourth Quarter and Full Year 2013

[Jiayuan Announces Fourth Quarter and Full Year 2013 Financial Results BEIJING, China, February 27, 2014 — Jiayuan.com International Ltd. (“Jiayuan”) (NASDAQ: DATE), operator of the largest online dating platform in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter 2013 Highlights 1 · Net revenues for the fourth quarter] [333-173619 JIAYUAN.COM INTERNATIONAL LTD. F/15, Anhua Development Building No. 35 Anding Road Chaoyang District, Beijing The People’s Republic of China (8610) 6113-6312 Form 20-F o Form 40-F o o o Yes o No x 2]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 • Full] [EX-99.1 2]

MR [Mindray Medical International] 6-K: Mindray Announces 2013 Fourth Quarter and Full Year

[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 • Full] [EX-99.1 2]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China – March 3, 2014 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]

MR [Mindray Medical International] 6-K: Mindray Increases its Existing Share Repurchase Program by

[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China – March 3, 2014 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]

Skip to toolbar